Recent Advances in Endoscopy

Wallace, Michael B.; Wang, Kenneth K.; Adler, Douglas G.; Rastogi, Amit

doi:10.1053/j.gastro.2017.06.014

Cited by 20 publications

(15 citation statements)

References 143 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The colonoscopy was made in a standardized form and the personnel was blinded to patient group. To avoid the “Hawthorne effect” 14 , the endoscopists were unaware if a patient belonged to this study or was part of their normal clinical practice. Each endoscopist’s competency (MGM, AMZG and HEC) was certificated by the Mexican Council of Gastroenterology 15 , which takes into account ASGE guidelines 16 .…”

Section: Methodsmentioning

confidence: 99%

A short telephone-call reminder improves bowel preparation, quality indicators and patient satisfaction with first colonoscopy

et al. 2017

View full text Add to dashboard Cite

Background and study aims Addition of a reminder program to conventional indications improves colonoscopy. The aim of this study was to evaluate the effectiveness of a short telephone call reminder (STCR) on a patient’s first colonoscopy. Patients and methods One day before colonoscopy, we made a STCR of < 10 minutes to 141 randomly selected patients of 258 recruited. The STCRs informed patients about the procedure date, indications for taking laxatives, and dietetic requirements. Questions were clarified only when patients asked directly. We evaluated bowel preparation, quality indicators, and patient satisfaction. Data were expressed as mean ± SD and percentages. Statistical differences were evaluated by Student’s t and Chi squared tests; alpha = 0.05. All authors had access to the study data and reviewed and approved the final manuscript. Results The STCR group had better bowel preparation which was demonstrated by higher completion frequency (97.16 % vs. 82.05 %), in less time (4.52 ± 3.06 vs. 5.38 ± 3.03 hours) intake of laxative, and higher Boston’s scale (7.66 ± 2.42 vs. 5.2 ± 1.65). Quality indicators of colonoscopy were better in patients that received a STCR [cecal intubation rate: 100.00 % vs. 87.18 %; polyp detection: 42.55 % vs. 9.4 %; and cecal arrival time (min): 12.09 ± 3.62 vs. 15.09 ± 5.02]. STCR patients were more satisfied (97.87 % vs. 55.56 %) and would repeat colonoscopy (21.99 % vs. 11.11 %). Conclusions A simple additional step such as a STCR improves quality of bowel preparation, quality indicators, and satisfaction of patients undergoing their first colonoscopy. Clinical trial registry in Mexico City General Hospital: DI/16/107/3/108.

show abstract

Section: Methodsmentioning

confidence: 99%

A short telephone-call reminder improves bowel preparation, quality indicators and patient satisfaction with first colonoscopy

et al. 2017

View full text Add to dashboard Cite

show abstract

“…Recently, endoscopic or percutaneous focal ablation has been piloted to prolong ductal patency and debulk ingrowing tumors. 7 Intraductal RFA with an endobiliary catheter (Habib EndoHPB; EMcision, London, UK) has been designed to potentially improve the stent patency and survival rates. 8 However, because of heat sink and thermal injury, its clinical use was confined by the risk of treatment-related complications and limited efficacy.…”

mentioning

confidence: 99%

Acute and subacute effects of irreversible electroporation on normal common bile ducts in a rabbit model

Liu

Ren

Zhang

et al. 2020

J Hepato Biliary Pancreat

View full text Add to dashboard Cite

BACKGROUND Malignant biliary tumors are uncommon and usually diagnosed following malignant biliary obstruction. 1 Surgical resection is currently the only potential curative treatment for early recognition and diagnosis. However, a majority of patients present late in the course of disease with only 20%-40% resectable cases due to the advanced tumor stage at the time of diagnosis, and of these potentially resectable tumors, R 0 resection is not always achieved. 2 Therefore, placement of biliary stents is typically chosen as palliative management for biliary decompression with an estimated life expectancy of approximately 3-6 months. 3,4 Compared with surgical interventions, biliary stents offer shorter durations

show abstract

“…Furthermore, they can only be performed in centers with experienced gastroenterologists. [ 5 ] Therefore, more than 2/3 of EHCC patients with definitive diagnoses are in late stage and have missed the opportunity for radical surgery. [ 6 ] The survival time of patients with unresectable EHCC was usually only 6-9 months.…”

Section: Introductionmentioning

confidence: 99%

Serum mucin 3A as a potential biomarker for extrahepatic cholangiocarcinoma

Wang¹,

Zhou²,

Wang³

et al. 2020

Saudi J Gastroenterol

View full text Add to dashboard Cite

Background/Aims: The aim of this study is to evaluate serum mucin 3A (MUC3A) as a candidate biomarker for extrahepatic cholangiocarcinoma (EHCC). Patients and Methods: 35 Patients with EHCC, 30 patients with pancreatic cancer, 35 patients with gallbladder carcinoma and 78 patients with benign biliary disease were enrolled during January 2015 to January 2016. Serum MUC3A, carbohydrate antigen 19-9 (CA19-9) and carcinoembryonic antigen (CEA) were measured in these patients. Pathology reports of patients with EHCC were collected. Results: (1) The serum levels of MUC3A (87.3 ± 10.8 ng/ml) in patients with EHCC were higher than in patients with pancreatic cancer (63.2 ± 7.7 ng/ml, P < 0.001), patients with gallbladder carcinoma (59.0 ± 10.3 ng/ml, P < 0.001) and patients with benign biliary disease (56.6 ± 13.1 ng/ml, P < 0.001). (2) ROC analysis showed that using MUC3A could clearly distinguish patients with EHCC from those without EHCC with a threshold of 73.2 ng/ml. (3) According to ROC analysis, the sensitivity, specificity, and accuracy of serum MUC3A for diagnosis of EHCC were 94.3%, 89.5% and 90.4%, respectively, which were all significantly higher than CA19-9 and CEA. (4) The serum levels of MUC3A at 1 month post-operatively in 35 patients with EHCC were decreased compared to pre-operative levels (51.8 ± 5.6 vs. 87.3 ± 10.8 ng/ml, P < 0.01). (5) Compared with 20 patients with low MUC3A levels (≤88.8 ng/ml), 15 patients with high MUC3A levels (>88.8 ng/ml) had higher percentage of lymph node metastasis (66.7% vs. 25%, P = 0.014), surrounding tissue infiltration (80% vs. 30%, P = 0.003), and UICC staging IIa-III (86.7% vs. 35%, P = 0.002). Conclusion: The diagnostic efficiency for EHCC of MUC3A is obviously superior to CA19-9 and CEA, and a high level of serum MUC3A indicates a poor prognosis, therefore, MUC3A can be used as a potential diagnostic and prognostic biomarker for EHCC.

show abstract

Recent Advances in Endoscopy

Cited by 20 publications

References 143 publications

A short telephone-call reminder improves bowel preparation, quality indicators and patient satisfaction with first colonoscopy

A short telephone-call reminder improves bowel preparation, quality indicators and patient satisfaction with first colonoscopy

Acute and subacute effects of irreversible electroporation on normal common bile ducts in a rabbit model

Serum mucin 3A as a potential biomarker for extrahepatic cholangiocarcinoma

Contact Info

Product

Resources

About